Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


1 Ann Oncol
7 Br J Cancer
1 Cancer
1 Clin Cancer Res
2 Eur J Surg Oncol
1 Gastroenterology
2 J Nucl Med
1 Oncogene
2 Oncol Rep
1 Oncology
1 PLoS Genet
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Oncol

  1. WILLIS JA, Vilar E
    Refining Prognosis in Early-Stage Colorectal Cancer: One or multiple genes at a time?
    Ann Oncol. 2017 May 26. doi: 10.1093.
    PubMed     Text format    

    Br J Cancer

  2. HUANG J, Mondul AM, Weinstein SJ, Koutros S, et al
    Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Br J Cancer. 2016 Sep 27. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

  3. JONES CM, Goh V, Sebag-Montefiore D, Gilbert DC, et al
    Biomarkers in anal cancer: from biological understanding to stratified treatment.
    Br J Cancer. 2017;116:156-162.
    PubMed     Text format     Abstract available

  4. CREAVIN B, Ryan E, Martin ST, Hanly A, et al
    Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
    Br J Cancer. 2017;116:169-174.
    PubMed     Text format     Abstract available

  5. ENGLINGER B, Mair M, Miklos W, Pirker C, et al
    Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance.
    Br J Cancer. 2017;116:489-500.
    PubMed     Text format     Abstract available

  6. SCHIFFMANN LM, Brunold M, Liwschitz M, Goede V, et al
    A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition.
    Br J Cancer. 2017;116:600-608.
    PubMed     Text format     Abstract available

  7. FURLAN D, Trapani D, Berrino E, Debernardi C, et al
    Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis.
    Br J Cancer. 2017;116:793-801.
    PubMed     Text format     Abstract available

  8. MALAPELLE U, Mayo de-Las-Casas C, Rocco D, Garzon M, et al
    Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
    Br J Cancer. 2017;116:802-810.
    PubMed     Text format     Abstract available


  9. XU Z, Mohile SG, Tejani MA, Becerra AZ, et al
    Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Cancer. 2017;123:52-61.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  10. STIEGELBAUER V, Vychytilova-Faltejskova P, Karbiener M, Pehserl AM, et al
    MicroRNA-196b-5p regulates colorectal cancer cell migration and metastases through interaction of HOXB7 and GALNT5.
    Clin Cancer Res. 2017 May 22. pii: clincanres.0023.2017.
    PubMed     Text format     Abstract available

    Eur J Surg Oncol

  11. ASKLID D, Segelman J, Gedda C, Hjern F, et al
    The impact of perioperative fluid therapy on short-term outcomes and 5-year survival among patients undergoing colorectal cancer surgery - A prospective cohort study within an ERAS protocol.
    Eur J Surg Oncol. 2017 May 3. pii: S0748-7983(17)30445.
    PubMed     Text format     Abstract available

  12. FLEMMING JA, Nanji S, Wei X, Webber C, et al
    Association between the time to surgery and survival among patients with colon cancer: A population-based study.
    Eur J Surg Oncol. 2017 May 6. pii: S0748-7983(17)30456.
    PubMed     Text format     Abstract available


  13. YAEGER R, Shah MA, Miller VA, Kelsen JR, et al
    Genomic Alterations Observed in Colitis-associated Cancers are Distinct from Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
    Gastroenterology. 2016 Apr 7. pii: S0016-5085(16)30053.
    PubMed     Text format     Abstract available

    J Nucl Med

  14. ELVAS F, Boddaert J, Vangestel C, Pak K, et al
    99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET.
    J Nucl Med. 2016 Nov 22. pii: jnumed.116.182014.
    PubMed     Text format     Abstract available

  15. KATIYAR P, Divine MR, Kohlhofer U, Quintanilla-Martinez L, et al
    Spectral Clustering predicts tumor tissue heterogeneity using dynamic 18F-FDG PET: a complement to the standard compartmental modeling approach.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.181370.
    PubMed     Text format     Abstract available


  16. UNGER C, Kramer N, Unterleuthner D, Scherzer M, et al
    Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

    Oncol Rep

  17. ZENG YH, Zhou LY, Chen QZ, Li Y, et al
    Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5662.
    PubMed     Text format     Abstract available

  18. SUN Y, Ji B, Feng Y, Zhang Y, et al
    TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5654.
    PubMed     Text format     Abstract available


  19. LARSEN FO, Markussen A, Nielsen D, Colville-Ebeling B, et al
    Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer.
    Oncology. 2017 May 23. doi: 10.1159/000475818.
    PubMed     Text format     Abstract available

    PLoS Genet

  20. UCHI R, Takahashi Y, Niida A, Shimamura T, et al
    Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.
    PLoS Genet. 2017;13:e1006798.
    PubMed     Text format     Abstract available

    PLoS One

  21. Correction: Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
    PLoS One. 2017;12:e0178275.
    PubMed     Text format     Abstract available

  22. GONZALEZ-DONQUILES C, Alonso-Molero J, Fernandez-Villa T, Vilorio-Marques L, et al
    The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review.
    PLoS One. 2017;12:e0177549.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.